Literature DB >> 23060149

Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGFβ effects on cell proliferation and migration in prostate cancer cells.

Nicole Strong1, Ana C Millena, Lindsey Walker, Jaideep Chaudhary, Shafiq A Khan.   

Abstract

BACKGROUND: In prostate cancer cells, transforming growth factor β (TGFβ) inhibits proliferation in earlier stages of the disease; however, the cancer cells become refractory to growth inhibitory effects in advanced stages where TGFβ promotes cancer progression and metastasis. Inhibitor of differentiation (Id) family of closely related proteins (Id1-Id4) are dominant negative regulators and basic helix loop helix (bHLH) transcription factors and in general promote proliferation, and inhibit differentiation. In the present study, we have investigated the role of Id1 and Id3 proteins in the growth inhibitory effects of TGFβ on prostate cancer cells.
METHODS: The effect of TGF β on proliferation and Id1 and Id3 expression were investigated in PZ-HPV7, DU145, and PC3 cells. Id1 silencing through siRNA was also used in DU145 and PC3 cells to examine its role in anti-proliferative and migratory effects of TGFβ.
RESULTS: TGFβ increased expression of Id1 and Id3 in all cell lines followed by a later down regulation of Id1 in PZ-HPV7 expression and DU145 cells but not in PC3 cells. Id3 expression remained elevated in all three cell lines. This loss of Id1 protein correlated with an increase of CDKNI p21. Id1 knockdown in both DU145 and PC3 cells resulted in decreased proliferation. However, while TGFβ caused a further decrease in proliferation of DU145, but had no further effects in PC3 cells. Knockdown of Id1 or Id3 inhibited TGFβ1induced migration in PC3 cells.
CONCLUSIONS: These findings suggest an essential role of Id1 and Id3 in TGFβ1 effects on proliferation and migration in prostate cancer cells.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23060149      PMCID: PMC4018743          DOI: 10.1002/pros.22603

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  41 in total

Review 1.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

2.  [Expression of ID3 protein in prostate cancer and its clinicopathological significance].

Authors:  Kai Wang; Xiao-jun Li; Hong-lin Yin; Hang-bo Zhou; Fang-fang Chen; Hai Wang; Heng-hui Ma
Journal:  Zhonghua Nan Ke Xue       Date:  2011-05

Review 3.  Smad transcription factors.

Authors:  Joan Massagué; Joan Seoane; David Wotton
Journal:  Genes Dev       Date:  2005-12-01       Impact factor: 11.361

Review 4.  TGF-beta biology in mammary development and breast cancer.

Authors:  Harold Moses; Mary Helen Barcellos-Hoff
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

5.  Prohibitin and cofilin are intracellular effectors of transforming growth factor beta signaling in human prostate cancer cells.

Authors:  Beibei Zhu; Kei Fukada; Haining Zhu; Natasha Kyprianou
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

6.  Inhibitor of DNA binding-1 induces mesenchymal features and promotes invasiveness in thyroid tumour cells.

Authors:  Alessia Ciarrocchi; Simonetta Piana; Roberto Valcavi; Giorgio Gardini; Bruno Casali
Journal:  Eur J Cancer       Date:  2010-12-09       Impact factor: 9.162

7.  Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration.

Authors:  A V Bakin; A K Tomlinson; N A Bhowmick; H L Moses; C L Arteaga
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

8.  Increased TGF-β1-mediated suppression of growth and motility in castrate-resistant prostate cancer cells is consistent with Smad2/3 signaling.

Authors:  Fayth L Miles; Navpreet S Tung; Adam A Aguiar; Senem Kurtoglu; Robert A Sikes
Journal:  Prostate       Date:  2012-01-06       Impact factor: 4.104

9.  Osteoblast conditioned media contain TGF-beta1 and modulate the migration of prostate tumor cells and their interactions with extracellular matrix components.

Authors:  C Festuccia; M Bologna; G L Gravina; F Guerra; A Angelucci; I Villanova; D Millimaggi; A Teti
Journal:  Int J Cancer       Date:  1999-05-05       Impact factor: 7.396

10.  Expression of transforming growth factor-beta 1 in prostate cancer.

Authors:  M S Steiner; Z Z Zhou; D C Tonb; E R Barrack
Journal:  Endocrinology       Date:  1994-11       Impact factor: 4.736

View more
  18 in total

1.  JunD Is Required for Proliferation of Prostate Cancer Cells and Plays a Role in Transforming Growth Factor-β (TGF-β)-induced Inhibition of Cell Proliferation.

Authors:  Ana Cecilia Millena; BaoHan T Vo; Shafiq A Khan
Journal:  J Biol Chem       Date:  2016-06-29       Impact factor: 5.157

2.  TGF-β1-induced expression of Id-1 is associated with tumor progression in gastric cancer.

Authors:  Huiying Ma; Ye Wei; Yongmei Leng; Shichao Li; Lingling Gao; Heng Hu; Long Chen; Fei Wang; Honglei Xiao; Chouwen Zhu; Chunmin Liang
Journal:  Med Oncol       Date:  2014-05-27       Impact factor: 3.064

3.  TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.

Authors:  Cachétne S X Barrett; Ana C Millena; Shafiq A Khan
Journal:  Prostate       Date:  2016-09-07       Impact factor: 4.104

4.  Differential role of PTEN in transforming growth factor β (TGF-β) effects on proliferation and migration in prostate cancer cells.

Authors:  Mawiyah N Kimbrough-Allah; Ana C Millena; Shafiq A Khan
Journal:  Prostate       Date:  2018-01-16       Impact factor: 4.104

5.  Ethnic differences in TGFβ-signaling pathway may contribute to prostate cancer health disparity.

Authors:  Bethtrice Elliott; DeAdra L Zackery; Vanessa A Eaton; Re'Josef T Jones; Fisseha Abebe; Camille C Ragin; Shafiq A Khan
Journal:  Carcinogenesis       Date:  2018-04-05       Impact factor: 4.944

6.  ITF2357 transactivates Id3 and regulate TGFβ/BMP7 signaling pathways to attenuate corneal fibrosis.

Authors:  Rayne R Lim; Alison Tan; Yu-Chi Liu; Veluchamy A Barathi; Rajiv R Mohan; Jodhbir S Mehta; Shyam S Chaurasia
Journal:  Sci Rep       Date:  2016-02-11       Impact factor: 4.379

7.  Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation.

Authors:  Marianna Papaspyridonos; Irina Matei; Yujie Huang; Maria do Rosario Andre; Helene Brazier-Mitouart; Janelle C Waite; April S Chan; Julie Kalter; Ilyssa Ramos; Qi Wu; Caitlin Williams; Jedd D Wolchok; Paul B Chapman; Hector Peinado; Niroshana Anandasabapathy; Allyson J Ocean; Rosandra N Kaplan; Jeffrey P Greenfield; Jacqueline Bromberg; Dimitris Skokos; David Lyden
Journal:  Nat Commun       Date:  2015-04-29       Impact factor: 14.919

8.  New role of ID3 in melanoma adaptive drug-resistance.

Authors:  Lionel Larribère; Daniel Novak; Huizi Wu; Laura Hüser; Karol Granados; Elias Orouji; Jochen Utikal
Journal:  Oncotarget       Date:  2017-11-27

9.  Role of ID Proteins in BMP4 Inhibition of Profibrotic Effects of TGF-β2 in Human TM Cells.

Authors:  Avani A Mody; Robert J Wordinger; Abbot F Clark
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-02-01       Impact factor: 4.799

Review 10.  Inhibitor of Differentiation 1 (Id1) in Cancer and Cancer Therapy.

Authors:  Zhengxiao Zhao; Zhiyuan Bo; Weiyi Gong; Yong Guo
Journal:  Int J Med Sci       Date:  2020-04-06       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.